TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
Biobank AS
Closing information (x1000 NOK)
Closing information | 2019/12 | 2018/12 | 2017/12 |
Turnover | 18,610 | 16,259 | 16,386 |
Financial expenses | 57 | 66 | 87 |
Earnings before taxes | 2,149 | 1,761 | 2,265 |
Total assets | 13,124 | 10,851 | 9,253 |
Current assets | 10,136 | 7,075 | 5,681 |
Current liabilities | 2,469 | 2,043 | 1,832 |
Equity capital | 7,347 | 5,647 | 5,530 |
- share capital | 300 | 300 | 300 |
Shareholders | 0 | 0 | 0 |
Financial ratios
Fiscal year | 2019/12 | 2018/12 | 2017/12 |
Solvency | 56.0% | 52.0% | 59.8% |
Turnover per employee | |||
Profit as a percentage of turnover | 11.5% | 10.8% | 13.8% |
Return on assets (ROA) | 16.8% | 16.8% | 25.4% |
Current ratio | 410.5% | 346.3% | 310.1% |
Return on equity (ROE) | 29.3% | 31.2% | 41.0% |
Change turnover | 2,351 | -127 | 6,081 |
Change turnover % | 14% | -1% | 59% |
Chg. No. of employees | |||
Chg. No. of employees % |
Total value of public sale
Fiscal year | 2019/12 | 2018/12 | 2017/12 |
Total value of public sale | 0 | 0 | 0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.